(Bi-Monthly) is one of India’s leading
Pharma journals, appropriately referred
to as the Umbrella Journal of the
Pharma Industry. Abstracted and Indexed
by the International Pharmaceutical
Abstracts, USA and Chemical Abstracts,
USA, the magazine provides an excellent
platform for authors, researchers and
Also available in digital format on CD
Rom, the journal has readership in over
15 countries, provides media support to
Pharma Expos worldwide and has
advertisers from Bangladesh, China,
Iran, Pakistan & Taiwan apart from
Receives FDA Fast Track Designation
for Evofosfamide for Treatment of
Patients Living With Advanced
Commercial Conflict of Interests
Justifiable in Medical Journals?
Pharma Sector Welcomes India's
Intellectual Property Policy
Co. Announces Multi-Year, World-Wide
PhysioPD™ Research Agreement with
Acquires Minority Interest in AM-Pharma;
Secures Option to Acquire Company
Biopsy' Using Blood Test is Latest
Weapon Against Cancer
Soon to Fix Heart Attack Tear?
Test Spots Tumors Earlier Than CT
countries across the globe have
established or are in the process of
establishing sound drug regulatory
systems in keeping with the need of
providing safe and cost effective
medication for their people....
Editorial Board of The Pharma Review
comprises of eminent pharma
personalities from India and abroad.
Review regularly conducts interviews of
a cross section of industry
personalities. To read more, click here.